An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 104 of the 105 references it cites were found in a registry or an index.
Abstract
Oxidative stress has been linked with a variety of diseases, being involved in the debut and/or progress of several neurodegenerative disorders. This review intends to summarize some of the findings that correlate the overproduction of reactive oxygen species with the pathophysiology of Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. Oxidative stress was also noted to modify the inflammatory response. Even though oxidative stress and neuroinflammation are two totally different pathological events, they are linked and affect one another. Nonetheless, there are still several mechanisms that need to be understood regarding the onset and the progress of neurodegenerative diseases in order to develop efficient therapies. As antioxidants are a means to alter oxidative stress and slow down the symptoms of these neurodegenerative diseases, the most common antioxidants, enzymatic as well as non-enzymatic, have been mentioned in this paper as therapeutic options for the discussed disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Generally known reactive oxygen species (ROS). Adapted from [13].](https://figures.cochat.ai/paper-figures/9dc1d012e9e34e18822030ec89569bfb/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-1.jpg)
![Figure 2 Dopamine metabolism and ROS production. Reprinted from an open-access source [21].](https://figures.cochat.ai/paper-figures/3cc9438ebe354aeab026d8ea3f0ad7cc/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-2.jpg)
![Figure 3 Schematic representation of alterations in dopamine, iron, and alfa-synuclein promoting oxidative stress in the substantia nigra pars compacta. Reprinted from an open-access source [21].](https://figures.cochat.ai/paper-figures/79d7743213bd4acd8dc276da40dae43e/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-3.jpg)
![Figure 4 The model of motor nerve terminal dysregulation in ALS. (A) Healthy NMJ. (B) Pathological changes in NMJ during early stage of ALS. (C) Pathological changes in NMJ during late stage of ALS. Abbreviations: Ach—acetyl choline, MuSK—muscle-specific kinase, NMJ—neuromuscular junction, ROS—reactive oxygen species, TSC—terminal Schwann. Reprinted from an open-access source [34].](https://figures.cochat.ai/paper-figures/2e64b95026e34c5ab6b7ccd689373902/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-4.jpg)
![Figure 5 Representation of ROS-induced mitochondrial abnormalities in AD. Reprinted from an open-access source [9].](https://figures.cochat.ai/paper-figures/43a7b1a13867494ca7957071279194b2/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-5.jpg)
![Figure 6 Mutant HTT (mHTT)-induced mitochondria-mediated reactive oxygen species (ROS) accumulation. Adapted from [62].](https://figures.cochat.ai/paper-figures/b96903214a6042b4b49c7465333ed8f1/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-6.jpg)
![Figure 7 Overview of microglial functions in response to stress and AD pathology. Adapted from [71].](https://figures.cochat.ai/paper-figures/982c0e0a6c73429884ec1275432bb076/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within this context, ω3 are able to ameliorate oxidative stress and neuroinflammation, which may explain part of their beneficial effects on PD [457].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [457]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
Ighodaro, O. M., & Akinloye, O. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 3,939
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 4×
“In more detail, high oxygen consumption, low antioxidant levels, and low regenerative capacity were observed to induce oxidative damage susceptibility in brain tissues [7].”
BackgroundInfluentialOxidative Stress: A Key Modulator in Neurodegenerative Diseases
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,254
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · cited 1×
“Moreover, due to the lowering of estrogen levels during menopause and longer life expectancy, women are more likely to develop AD than men [42,43].”
BackgroundOxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · cited 2×
“sible for learning and memory, which are affected in AD brains [48].”
BackgroundA blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853 · cited 1×
“Because the therapeutic agents need to reach the central nervous system (CNS), it is necessary to tailor appropriate vectors that can surpass the brain–blood barrier (BBB) [3,6].”
BackgroundHardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.71 · Cited by 1,414
The role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355 · cited 9×
“dehydrogenase, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) [13,15].”
BackgroundInfluential13 reasons why the brain is susceptible to oxidative stress
Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215
Cited by
Items 201–300 of 1,000
What We Know about Euterpe Genus and Neuroprotection: A Scoping Review
Silva, I. O. D., Lopez, M. E. C., Augusto‐Oliveira, M., Arrifano, G. D. P., Ramos-Nunes, N. R., Gomes, E. B., da Silva, F. R. P., de Sousa, A. A., Leal, A. L. A. B., Damasceno, H. C., et al. (2023) · Nutrients · doi:10.3390/nu15143189 · Cited by 18
Kola, A., Vigni, G., Baratto, M. C., & Valensin, D. (2023) · Molecules · doi:10.3390/molecules28186629 · Cited by 17
Neuroprotective effects of hesperetin on H2O2-induced damage in neuroblastoma SH-SY5Y cells
Moon, H.-R., & Yun, J. (2023) · Nutrition Research and Practice · doi:10.4162/nrp.2023.17.5.899 · Cited by 19
“In addition, oxidative stress also characterizes acute and chronic illnesses, including neurodegenerative diseases [32].”
PET imaging of synaptic density in Parkinsonian disorders
Martin, S. L., Uribe, C., & Strafella, A. P. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25253 · Cited by 22
“…with neurodegeneration and is related to the progression in a variety of diseases (Chen et al., 2016; Kwon & Koh, 2020; McManus & Heneka, 2017; Teleanu et al., 2022; Ward et al., 2022), it would be interesting to establish the spatiotemporal relationship between neuroinflammation and synaptic…”
BackgroundShao, S., Zou, Y. Z., Kennedy, K. G., Dimick, M. K., MacIntosh, B. J., & Goldstein, B. I. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad063 · Cited by 17
“Neuroinflammation could further affect brain structure through a cascade of inter-related processes involving oxidative stress, apoptosis, and synaptic alterations (Fabisiak and Patel, 2022; Teleanu et al., 2022).”
BackgroundSong, L.-J., Han, Q.-X., Ding, Z., Liu, K., Zhang, X., Guo, M., Ma, D., Wang, Q., Xiao, B., & Ma, C. (2024) · Inflammopharmacology · doi:10.1007/s10787-023-01388-6 · Cited by 19
“The inflammatory process can induce oxidative stress that, in turn, also fuels inflammation through activation of multiple pathways (Teleanu et al. 2022).”
Kaur, N., & Aran, K. R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01641-0 · Cited by 19
“Neuroinflammation and oxidative stress cause an imbalance in the production of free radical production that damages the cells and triggers inflammatory responses (Teleanu et al. 2022).”
STING-inflammasome axis in autoimmune diseases and inflammation-related disease
Chai, S., Xu, H., Liu, R., & Cai, C. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103898 · Cited by 17
Ghosh, S., Debnath, I., Bhunia, S., Nandi, S., Ashique, S., Nayak, A., Mallick, S., & Basak, S. (2025) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2025.09.005 · Cited by 32
Nitric oxide-modulating biomaterials for therapeutic Immunoengineering
Boo, Y., Choi, S., Kim, J., & Kim, W. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115718 · Cited by 18
Wang, Y., Zou, J., Wang, Y., Wang, J., Ji, X., Zhang, T., Chu, Y., Cui, R., Zhang, G., Shi, G., et al. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109706 · Cited by 16
Masitinib as a neuroprotective agent: a scoping review of preclinical and clinical evidence
Hamad, A. A., Amer, B. E., Hawas, Y., Mabrouk, M. A., & Meshref, M. M. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07259-w · Cited by 16
Emerging Perspectives on Prime Editor Delivery to the Brain
BenDavid, E., Ramezanian, S., Lu, Y., Rousseau, J., Schroeder, A., Lavertu, M., & Tremblay, J. P. (2024) · Pharmaceuticals · doi:10.3390/ph17060763 · Cited by 17
“Among the CRISPR/Cas9 genome editing technologies, prime editing provides exceptional flexibility by allowing for the precision substitution of a target DNA sequence with nearly any other specified sequence containing up to several hundred inserted, deleted, or substituted base pairs [4,5].”
BackgroundAlkaptonuria: From Molecular Insights to a Dedicated Digital Platform
Milella, M. S., Geminiani, M., Trezza, A., Visibelli, A., Braconi, D., & Santucci, A. (2024) · Cells · doi:10.3390/cells13121072 · Cited by 16
“Several human pathological conditions present with oxidative stress and inflammation [14,15], such as neurodegenerative [16], autoimmune [17], rheumatic [18], and cardiovascular diseases [19], as well as cancer [20,21].”
BackgroundRetinasamy, T., Lee, A. L. Y., Lee, H. S., Lee, V. L. L., Shaikh, M. F., & Yeong, K. Y. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00205 · Cited by 18
Massaga, C. A., Paul, L., Kwiyukwa, L. P., Vianney, J., Chacha, M. N., & Raymond, J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.12.003 · Cited by 17
Huete-Acevedo, J., Mas‐Bargues, C., Arnal-Forné, M., Atencia-Rabadán, S., Sanz‐Ros, J., & Borrás, C. (2024) · Antioxidants · doi:10.3390/antiox13121493 · Cited by 16
The Therapeutic Potential of Supersulfides in Oxidative Stress-Related Diseases
Pan, Y., Matsunaga, T., Zhang, T., & Akaike, T. (2025) · Biomolecules · doi:10.3390/biom15020172 · Cited by 20
“Oxidative stress plays a fundamental role in neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease [102].”
Genetic evidence for the liver-brain axis: lipid metabolism and neurodegenerative disease risk
Wang, Z., Yin, Z., Sun, G., Zhang, D., & Zhang, J. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02455-3 · Cited by 18
“Recent studies have concluded that metabolic risk factors contribute to the occurrence and development of ND, suggesting promising strategies for prevention and treat-ment [4, 5].”
Etukudo, E. M., Usman, I. M., Oviosun, A., Ojiakor, V. O., Jama, I. A., Makena, W., Makeri, D., Owembabazi, E., Aja, P. M., Ifie, J. E., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1569527 · Cited by 16
Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure
Pena, E., Martin-Salamanca, R. S., Alam, S. E., Flores, K., & Arriaza, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020889 · Cited by 18
“Recent studies have shown a close relationship between cognitive function and oxidative stress, which can occur in OSA [144,145].”
BackgroundPramoda, G., Verma, R. K., Kesharwani, P., & Shukla, R. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.127938 · Cited by 15
de Almeida, P. D. O., Bozorgzadeh, S. A., Martins, I. J. F., & Golbashirzadeh, M. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-06915-4 · Cited by 15
“The excessive production of ROS and subsequent oxidative stress are linked to the development of numerous diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders [27].”
Eleiwa, N. Z. H., Ali, M. A.-A., Said, E. N., Metwally, M. M. M., & Abd‐Elhakim, Y. M. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-28538-1 · Cited by 18
de Mello, J. E., Teixeira, F. C., dos Santos, A., Luduvico, K. P., Soares, M. S. P., Domingues, W. B., Campos, V. F., Tavares, R. G., Schneider, A., Stefanello, F. M., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04062-2 · Cited by 16
Xu, Q., Chen, Y., Chen, D., & Reddy, M. B. (2024) · Nutrition and Metabolic Insights · doi:10.1177/11786388241253436 · Cited by 16
“Considerable evidence from in vitro and in vivo studies suggests that inflammation is related to ROS generation in PD, 36,37 and increased ROS level could augment the inflammation process, 38,39 thereby exacerbating neuronal damage.”
BackgroundPanda, P., Kar, S. S., & Mohapatra, R. (2024) · Next Materials · doi:10.1016/j.nxmate.2024.100336 · Cited by 18
Lu, R., Zhou, X., Zhang, L., 张明阳, & Yang, X. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s478683 · Cited by 15
“NLRP3 inflammasome-mediated neuroinflammation in microglia plays a crucial role in the innate immune response in PD. 26 Mitochondrial dysfunction and NLRP3 activation are emerging as critical players in inducing and sustaining neuroinflammation.”
BackgroundInfluentialKhan, J., Zainab, S. R., Rehman, M. U., Abid, M., Shah, F. A., Rehman, N. U., & Tipu, M. K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1446304 · Cited by 19
Hossaini, D., Alipour, A. K., Sajjadi, M., Ansari, M., & Haidary, M. (2025) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12523 · Cited by 17
“Oxidative stress is linked to various neurological conditions, including neurodegenerative and neuropsychiatric diseases [61], neuroinflammation [62, 63], and disrupted neurotransmitter systems [64, 65], suggesting it may play a role in their pathogenesis.”
Lin, Z.-X., Wang, C., Tu, H.-W., Tsai, M.-T., Yu, M.-H., & Huang, H. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c09422 · Cited by 20
Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective Agents
Juric, M., Rawat, V., Amaradhi, R., Zielonka, J., & Ganesh, T. (2023) · Antioxidants · doi:10.3390/antiox12091660 · Cited by 14
“Oxidative stress has been associated with the initiation and progression of various neurological disorders [47–49].”
BackgroundFeng, H., Zhang, Z., Lyu, W., Kong, X., Li, J., Zhou, H., & Wei, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03864-0 · Cited by 15
Evaluation of probiotic properties of a Brevibacillus laterosporus strain
Cao, Y., Wang, Z., Dai, X., Zhang, D., Zeng, Y., Ni, X., & Pan, K. (2024) · The FASEB Journal · doi:10.1096/fj.202302408r · Cited by 16
“92 Reactive oxygen species (ROS) is a general term for chemical substances formed by incomplete reduction of oxygen molecules, 93 which is associated with many conditions such as cancer, 94 neurodegenerative disease, 95 cardiovascular disease, 96 and so on.”
BackgroundDang, R., Hou, X., Huang, X., Huang, C., Zhao, X., Wang, X., Zhang, N., Yang, Y., Li, N., Liu, S., et al. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02192-9 · Cited by 15
“In recent years, oxidative stress damage associated with mitochondrial dysfunction has also become a hot topic of concern (Teleanu et al. 2022; Rehman et al. 2023).”
Nanoparticle-based Gene Therapy for Neurodegenerative Disorders
Ereej, N., Hameed, H., Khan, M. A., Faheem, S., & Hameed, A. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575301011240407082559 · Cited by 15
Alanazi, N., Fitzgerald, M., Hume, P. A., Hellewell, S. C., Horncastle, A., Anyaegbu, C. C., Papini, M. G., Hargreaves, N., Halicki, M., Entwistle, I. R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147811 · Cited by 16
Róg, J., Łobejko, Ł., Hordejuk, M., Marciniak, W., Derkacz, R., Kiljańczyk, A., Matuszczak, M., Lubiński, J., Nesterowicz, M., Żendzian‐Piotrowska, M., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1441575 · Cited by 14
Au, H. C. T., Lam, P. H., Lim, P. K., & McIntyre, R. S. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106159 · Cited by 20
Hafeez, E., Du, D., Ni, H., Zhu, K., Hu, F., Zhou, J., & Chen, D. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143382 · Cited by 15
Mitochondria-targeted rosmarinic acid: Its role against oxidative damage
Girgenti, A., Picone, P., Buttacavoli, M., Palumbo, L., Naselli, F., Presti, E. L., Pecora, D., Cipollina, C., Annunziata, F., Pinto, A., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118114 · Cited by 14
Neurodegenerative disease and antioxidant biomarkers: A bidirectional Mendelian randomization study
Zhang, Q., Li, Q., Zhao, H., Shu, M., Luo, M., Li, Y., Ding, Y., Shi, S., Cheng, X., & Niu, Q. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1158366 · Cited by 15
“They can control the level of oxidative stress and form minor reactive species via radicals, protecting the cell from being damaged (43, 44).”
BackgroundCystathionine β-Synthase Suppresses NLRP3 Inflammasome Activation via Redox Regulation in Microglia
Mou, Y.-J., Ma, Y., Yuan, X., Wang, M., Liu, Y., Pei, C., Liu, C., Hou, X., & Hu, L. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0174 · Cited by 16
“Neuroinflammation and oxidative stress are closely related and greatly contribute to PD pathogenesis (He et al., 2020; Teleanu et al., 2022).”
Effects and mechanisms of bisphenols exposure on neurodegenerative diseases risk: A systemic review
Xu, Y., Nie, J., Lu, C., Hu, C., Chen, Y., Ma, Y., Huang, Y., & Lu, L. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170670 · Cited by 15
Bjørklund, G., Butnariu, M., Caunii, A., & Peana, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05672-8 · Cited by 13
Zhang, M., Zheng, H., He, J., & Zhang, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21800 · Cited by 18
Tang, Y., Gu, W., & Cheng, L. (2023) · Environmental Toxicology · doi:10.1002/tox.24035 · Cited by 13
“26,27 EVO can neutralize or scavenge free radicals generated within the body, thereby reducing the oxidative damage.”
BackgroundNLRP3 Inflammasome Triggers Inflammation of Obstructive Sleep Apnea
Yangzhong, X., Hua, S., Wen, Y., Bi, X., Li, M., Zheng, Y., & Sun, S. (2024) · Current Molecular Medicine · doi:10.2174/0115665240294605240426123650 · Cited by 14
Assessing Alzheimer's disease via plasma extracellular vesicle–derived mRNA
Pham, L. H. P., Chang, C., Tuchez, K., Liu, F., & Chen, Y. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70006 · Cited by 15
Hassan, A., Huang, Y., Mahjabina, Sudiro, O. H., Wang, X., He, J., Wei, Y., Liao, X., & Wang, G. (2024) · iMetaOmics. · doi:10.1002/imo2.33 · Cited by 16
“An overabundance of ROS in NDs damages cells, especially in highly vulnerable neurons with rapid oxygen demand and inadequate anti ‐ oxidative ability [153].”
Andrew, P. M., MacMahon, J. A., Bernardino, P. N., Tsai, Y., Hobson, B. A., Porter, V. A., Huddleston, S. L., Luo, A., Bruun, D. A., Saito, N. H., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03272-8 · Cited by 14
“Context influences the impact of neuroinflammation on central nervous system (CNS) recovery following insult, and accumulating evidence indicates that some inflammatory processes may be beneficial while others are harmful [32, 33].”
BackgroundInfluentialReinforcing Nrf2 Signaling: Help in the Alzheimer’s Disease Context
la Torre, A., Vecchio, F. L., Angelillis, V. S., Gravina, C., D’Onofrio, G., & Greco, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031130 · Cited by 15
Promising Natural Remedies for Alzheimer’s Disease Therapy
Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2025) · Molecules · doi:10.3390/molecules30040922 · Cited by 14
“…for natural treatments for AD include mechanisms of action, wherein treatments must focus on important clinical characteristics of AD, including oxidative stress, tau hyperphosphorylation, amyloid-beta plaque formation, and neuroin-flammation [18,19]. into e ff ective AD therapy alternatives [17].”
InfluentialUnveiling exosomal biomarkers in neurodegenerative diseases: LC-MS-based profiling
Bi, Y.-L., Wang, L., Li, C., Shan, Z. J., & Bi, L. (2025) · Extracellular Vesicle · doi:10.1016/j.vesic.2025.100071 · Cited by 14
Gan, Y., Xie, N., & Zhang, D. (2025) · Chemistry · doi:10.3390/chemistry7050141 · Cited by 13
“Furthermore, excessive free radical attack also lead to dysfunction of cells, tissues, and organs and the development of chronic diseases such as diabetes, neurodegenerative disorders, cancer, and inflammatory diseases [11–14].”
Xu, W., Ren, B., Zhang, Z., Chen, C., Xu, T., Liu, S., Ma, C., Wang, X., Wang, Q., & Cheng, F. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.943400 · Cited by 13
“Oxidative stress can modify the inflammatory response, and it has been known that some ROS and reactive nitrogen species (RNS) could promote intracellular signaling cascades, which leads to increased expression of proinflammatory genes (Teleanu et al., 2022).”
Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis
Xu, X., Han, C., Wang, P., & Zhou, F. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1149963 · Cited by 13
“In MS, neuroinflammation and OS gradually destroy oligodendrocytes, eventually leading to a significant loss of myelin sheaths and the underlying axons in areas as diverse as the brainstem, spinal cord, and optical nerves (17).”
BackgroundArbutin's Potential in Neuroprotection: A Promising Role in Mitigating Neurodegenerative Diseases
SHARMA, A. K., Kakkar, A., Khanna, M., & Devi, S. (2024) · Current Drug Research Reviews · doi:10.2174/0125899775298987240528050110 · Cited by 12
How do HCN channels play a part in Alzheimer's and Parkinson's disease?
Zhang, Z., Luo, X., Jiang, L., Wu, H., & Tan, Z. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102436 · Cited by 12
Mani, V., & Arfeen, M. (2024) · Brain Sciences · doi:10.3390/brainsci14090876 · Cited by 12
“Overall, these”
Phytochemicals in Parkinson’s Disease: a Pathway to Neuroprotection and Personalized Medicine
Das, S., Rajeswari, V. D., Venkatraman, G., & Ramanathan, G. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01607-z · Cited by 20
Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases
Pang, J., Cen, C.-Q., Tian, Y., Cao, X., Hao, L., Tao, X., & Cao, Z. (2025) · Translational Psychiatry · doi:10.1038/s41398-024-03222-1 · Cited by 13
Reiriz, M., Beltrán-Velasco, A. I., Echeverry‐Alzate, V., Miguel, E. M., Gómez-Senent, S., Uceda, S., & Clemente‐Suárez, V. J. (2025) · Nutrients · doi:10.3390/nu17030391 · Cited by 14
“This inflammatory and oxidative environment can perpetuate neuronal damage through the alteration of synapses and the accumulation of intracellular aggregates, such as β -amyloid or α -synuclein, which are key characteristics of pathologies such as AD and PD [9,10].”
Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases
Denaro, S., D’Aprile, S., Vicario, N., & Parenti, R. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1532960 · Cited by 12
Etukudo, E. M., Usman, I. M., Oviosun, A., Ojiakor, V. O., Makena, W., Owembabazi, E., Aja, P. M., Vivalya, B. M. N., Archibong, V. B., & Anyanwu, G. E. (2025) · Journal of Experimental Pharmacology · doi:10.2147/jep.s536765 · Cited by 12
Sun, C., Cai, X., Jiang, X., Wen, F., & Wan, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178154 · Cited by 13
Perspectives on Alzheimer’s Disease Treatment Based on Counteracting Oxidative Stress
Bilski, R., Dąbkowski, S., Kozieł, I., Kozicki, M., Małachowska, A., Przygocki, M., & Tyska, O. (2025) · Biomolecules · doi:10.3390/biom15091345 · Cited by 13
Neural stem cells fate under neuroinflammatory conditions and oxidative stress response
Torrisi, F., Denaro, S., Ragonese, J., D’Aprile, S., Zappalà, A., & Parenti, R. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1736865 · Cited by 13
Volonté, C., Hu, G., Shaw, C. A., Claudio, V. J., dos Santos, J. A., Vaz, S. H., Sebastião, A. M., Balcar, V. J., Mozley, P. D., Verde, F., et al. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004136 · Cited by 14
Diniso, T., Adeyemi, J. O., Oriola, A. O., Elufioye, T. O., Gondwe, M. M., & Oyedeji, A. O. (2022) · Plants · doi:10.3390/plants11152066 · Cited by 17
“cholinergic deficit, oxidative stress, impaired mitochondrial function and neuroinflammation have been associated with NDs; thus, their management involves addressing one or more of the associated conditions [6].”
BackgroundXing, X., Xu, F., Wang, Y., & Liu, H. (2022) · Psychogeriatrics · doi:10.1111/psyg.12900 · Cited by 12
DTPA-Bound Planar Catechin with Potent Antioxidant Activity Triggered by Fe3+ Coordination
Fukuhara, K., Nakanishi, I., Imai, K., Mizuno, M., Matsumoto, K., & Ohno, A. (2023) · Antioxidants · doi:10.3390/antiox12020225 · Cited by 12
Huang, Z., & Tan, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098368 · Cited by 12
“Oxidative stress arises when an imbalance transpires between ROS production and the antioxidant defense mechanism [19].”
BackgroundChen, W., He, L., Pei, H., Li, J., Zhao, Y. D., Zong, Y., Kan, H., He, Z., & Du, R. (2023) · Aging · doi:10.18632/aging.204627 · Cited by 12
“Notably, studies have found that oxidative stress caused by abnormally increased production of reactive oxygen species (ROS) is closely related to AD in recent years [13, 14].”
BackgroundCopper: From enigma to therapeutic target for neurological disorder
Patwa, J., & Flora, S. J. S. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.14010 · Cited by 13
“27 The IB kinase (IkK) pathway is activated by increased ROS load, and it additionally activates MAP kinase, c-Jun amino-terminal kinases (JNK), and TNF receptor-related factor 1 (TRAF1) and 2 (TRAF2) that are the key inflammatory pathways.”
BackgroundFahmy, N. M., Fayez, S., Mohamed, R. W., Elissawy, A. M., Eldahshan, O. A., Zengin, G., & Singab, A. N. B. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04579-y · Cited by 12
Chen, C.-A., Li, C.-X., Zhang, Z., Xu, W., Liu, S., Ni, W.-C., Wang, X., Cheng, F., & Wang, Q. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116769 · Cited by 17
Research Progress of SERS Sensors Based on Hydrogen Peroxide and Related Substances
Ruan, S., Liu, W., Wang, W., & Lu, Y. (2023) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2023.2255901 · Cited by 11
“[9] In addition, H 2 O 2 is an intermediate molecule [10–14] formed in the reaction of various enzymes such as glucose oxidase, alcohol oxidase, cholesterol oxidase, lactate oxidase and glutamate oxidase and it is possible to measure the amount of H 2 O 2 as an intermediate ultimately allowing for…”
Anti‐aging effects of icariin and the underlying mechanisms: A mini‐review
Li, Y., Wei, Z., & Su, L. (2024) · Aging Medicine · doi:10.1002/agm2.12284 · Cited by 11
“26 ]).”
Zhang, W., Zhao, X., Bhuiyan, P., Liu, H., & Wei, H. (2024) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2024.04.002 · Cited by 12
“1 Many diseases can be classified into NDs.”
InfluentialThe role of Nrf2 signaling pathways in nerve damage repair
Abdolmaleki, A., Karimian, A., Khoshnazar, S. M., Asadi, A., Samarein, Z. A., Smail, S. W., & Bhattacharya, D. (2024) · Toxicology Research · doi:10.1093/toxres/tfae080 · Cited by 11
Bi, W., Mu, X., Li, Y., Sun, Q., Xiang, L., Hu, M., & Liu, H. (2024) · Human Cell · doi:10.1007/s13577-024-01086-7 · Cited by 11
“Oxidative stress damage is a common pathological mechanism in various neurodegenerative diseases [55], and it is closely related to abnormal nerve fiber tangles, neuroinflammatory reactions, and neuronal apoptosis [56, 57].”
Janpaijit, S., Sukprasansap, M., Tencomnao, T., & Prasansuklab, A. (2024) · Nutrients · doi:10.3390/nu16172882 · Cited by 12
“Furthermore, oxidative stress has been linked to neuroinflammation in neurodegenerative disease progression [61].”
BackgroundAntioxidant and Antimicrobial Properties of Probiotics: Insights from In Vitro Assays
Costa, F. F., Dias, T. G., Mendes, P. M., Viana, J. P. M., Madeira, E. B., Pereira, A. L. F., Ferreira, A. G. N., Neto, M. S., Dutra, R. P., Reis, A. S., et al. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10426-w · Cited by 11
Ling, L., Zhou, G., Zhang, X., Mao, B., Wan, S., & Bao, Y. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105739 · Cited by 11
He, Y., Ouyang, K., Yang, H., Wang, L., Zhang, Q., Li, D., & Li, L. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110126 · Cited by 14
Han, X. Y., Chen, X., Zheng, X., & Yan, F. (2025) · Food & Function · doi:10.1039/d4fo04639k · Cited by 12
Li, J., Wang, Z., Wei, Y., Li, W., He, M., Kang, J., Xu, J., & Liu, D. (2025) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.4c00085 · Cited by 11
Jahan, S., Ikram, M. A., Siraj, S., Ullah, S., Zakria, M., & Ahmad, N. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04762-3 · Cited by 15
Yang, S., Wang, L., Liang, X., Pei, T., Zeng, Y., Xie, B., Wang, Y., Yang, M., Wei, D., & Cheng, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141715 · Cited by 15
Ding, N., Wang, P., Yu, F., Hu, Y., Wang, W., Wei, J., Yu, J., & Cai, F. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110461 · Cited by 12
Advancements in extracellular vesicle therapy for neurodegenerative diseases
Hu, N., Chen, L., Hu, G., & Ma, R. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004104 · Cited by 15
“Examples include EVs loaded with curcumin, resveratrol, epigallocatechin gallate (EGCG), or N-acetylcysteine (NAC) for neuroprotection and disease-modifying effects in AD, PD, and ALS models [115–119].”
Asgari, Z., Iranzadeh, S., & Roghani, M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111382 · Cited by 14
Abdelghafour, A. M., Mahrous, M., & Zaher, M. E. (2025) · Food & Function · doi:10.1039/d4fo06458e · Cited by 11
Histone deacetylase 6: A new player in oxidative stress‑associated disorders and cancers (Review)
Qu, F., Zhao, Q., & Jin, Y. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5578 · Cited by 12
Cao, Y., Zhao, L., Li, Q., Song, B., Xu, Y., Jiang, L., & Li, S. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.165968 · Cited by 14
Alzarea, S. I. (2025) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-025-00026-2 · Cited by 12
“The progressive decline in cognitive abilities is the hallmark of AD, and the atrophy in the brain region is caused by neuron loss and the breakdown of synapses inside the hippocampus which is responsible for spatial orientation, learning, emotions, and memory formation (Teleanu et al. 2022).”
Advanced Therapeutic Approach Based on LDHs–Mimetic Oxidoreductase
Song, K., Yu, W., Jia, P., He, S., Wang, Q., Xu, M., Liu, H., Bao, P., Guan, S., & Qu, X. (2025) · Advanced Science · doi:10.1002/advs.202519115 · Cited by 19
He, Y., Qu, M., Yu, L., Lu, Y., Hong, J., Sun, M., Yang, H., Mi, W., Guo, H., & Ma, Y. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s588499 · Cited by 17
Rotenone-induced oxidative stress in THP-1 cells: biphasic effects of baicalin
Currò, M., Saija, C., Trainito, A., Salinaro, A. T., Bertuccio, M. P., Visalli, G., Caccamo, D., & Ientile, R. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08060-2 · Cited by 13
“Increased oxidative stress has been described as a common process occurring in multiple neurodegenerative disorders [6, 7].”
Background
Metadata
- Authors
- Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I.
- Affiliations
- Carol Davila University of Medicine and Pharmacy (RO)
- Universitatea Națională de Știință și Tehnologie Politehnica București (RO)
- National Institute for Laser Plasma and Radiation Physics (RO)
- Bucharest Emergency University Hospital (RO)
- Grigore T. Popa University of Medicine and Pharmacy (RO)
- University of Bucharest (RO)
- Corresponding author
- Grumezescu, Alexandru Mihai
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-05-25
- Volume
- 23
- Issue
- 11
- Pages
- 5938
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9180653
- OpenAlex
- W4281569188
- Cited by
- 1,085
- References
- 105
- Citations by year
- 2026: 270 · 2025: 405 · 2024: 254 · 2023: 132 · 2022: 23
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- oxidative stress, neuroinflammation, neurodegenerative diseases, reactive oxygen species, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, antioxidants, antioxidant enzymes, non-enzymatic antioxidants
- MeSH terms
- Neuroinflammatory Diseases, Antioxidants, Humans, Reactive Oxygen Species, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.